ROLLINS SCOTT A 4
4 · ALEXION PHARMACEUTICALS INC · Filed Nov 13, 2003
Insider Transaction Report
Form 4
ROLLINS SCOTT A
Sr. VP Drug Dev. & Proj. Man.
Transactions
- Award
Option to purchase Common Stock, par value $.0001 per share
2003-09-23+10,000→ 10,000 totalExercise: $17.67Exp: 2013-09-23→ Common Stock, par value $.0001 per share (10,000 underlying)
Footnotes (1)
- [F1]1/16th vests every 3 months following transaction date.